Xanthine Oxidase Inhibitor [EPC]

Xanthine Oxidase Inhibitor [EPC] was reported 173867 times

Drugs of the Xanthine Oxidase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 APPENDICOLITH 311 0.8036
1 SLEEP DISORDER THERAPY 128 0.6465
2 RED BLOOD CELL SEDIMENTATION RATE 129 0.4624
3 ANALGESIC THERAPY 145 0.4517
4 DRUG THERAPY 139 0.4100
5 GRANULOMA SKIN 151 0.1839
6 MULTIPLE DRUG THERAPY 133 0.1764
7 ENTHESOPATHY 266 0.1700
8 TUMOUR FLARE 114 0.1669
9 GOUTY ARTHRITIS 132 0.1654
10 GOUT 2944 0.1639
11 HYPERPARATHYROIDISM SECONDARY 394 0.1571
12 PRODUCT MONITORING ERROR 227 0.1571
13 HYPERPHOSPHATAEMIA 325 0.1510
14 NEPHROGENIC ANAEMIA 678 0.1462
15 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 147 0.1384
16 BLOOD URIC ACID INCREASED 798 0.1381
17 HYPERURICAEMIA 552 0.1342
18 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3057 0.1187
19 BLOOD PARATHYROID HORMONE DECREASED 174 0.1173
20 BLOOD PHOSPHORUS INCREASED 316 0.1156
21 TUMOUR LYSIS SYNDROME 997 0.1132
22 TENOSYNOVITIS 308 0.1116
23 SYSTEMIC INFECTION 158 0.0952
24 REBOUND ACID HYPERSECRETION 276 0.0911
25 AORTIC VALVE STENOSIS 159 0.0891
26 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 281 0.0865
27 TOXIC EPIDERMAL NECROLYSIS 1241 0.0816
28 PULMONARY FUNCTION TEST ABNORMAL 125 0.0802
29 PANNICULITIS 186 0.0768
30 RHEUMATOID NODULE 208 0.0754
31 ALANINE AMINOTRANSFERASE ABNORMAL 156 0.0739
32 DERMATITIS EXFOLIATIVE GENERALISED 251 0.0721
33 END STAGE RENAL DISEASE 1284 0.0703
34 BENIGN PROSTATIC HYPERPLASIA 354 0.0685
35 CYTOKINE RELEASE SYNDROME 1285 0.0640
36 CHRONIC LYMPHOCYTIC LEUKAEMIA 287 0.0604
37 CARDIAC FAILURE CHRONIC 257 0.0602
38 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 303 0.0598
39 ANAEMIA MACROCYTIC 127 0.0595
40 HYPERKALAEMIA 2067 0.0589
41 AORTIC STENOSIS 205 0.0588
42 IRON DEFICIENCY 263 0.0584
43 DIASTOLIC DYSFUNCTION 180 0.0583
44 NEUTROPENIC SEPSIS 406 0.0568
45 DRUG TOLERANCE DECREASED 157 0.0559
46 SPLENOMEGALY 651 0.0555
47 MYELOFIBROSIS 164 0.0542
48 STEVENS-JOHNSON SYNDROME 1180 0.0530
49 FEBRILE NEUTROPENIA 3508 0.0528
50 ORTHOPNOEA 167 0.0524
51 RENAL FAILURE CHRONIC 399 0.0518
52 DERMATITIS EXFOLIATIVE 256 0.0511
53 PLEURITIC PAIN 140 0.0507
54 TOXIC SKIN ERUPTION 504 0.0500
55 ACUTE KIDNEY INJURY 7645 0.0499
56 BLOOD UREA INCREASED 832 0.0496
57 CHRONIC KIDNEY DISEASE 3759 0.0494
58 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 432 0.0488
59 HYPOPHOSPHATAEMIA 357 0.0483
60 BRAIN NATRIURETIC PEPTIDE INCREASED 148 0.0480
61 EOSINOPHILIA 837 0.0477
62 TACHYARRHYTHMIA 118 0.0472
63 LUNG OPACITY 123 0.0466
64 ESCHERICHIA SEPSIS 135 0.0465
65 C-REACTIVE PROTEIN ABNORMAL 298 0.0464
66 LUNG CONSOLIDATION 129 0.0461
67 CHEST X-RAY ABNORMAL 141 0.0459
68 SKIN NECROSIS 238 0.0458
69 RENAL FAILURE ACUTE 1939 0.0456
70 HYPERCALCAEMIA 563 0.0456
71 AZOTAEMIA 181 0.0453
72 RALES 259 0.0446
73 RASH MORBILLIFORM 123 0.0443
74 APPENDICITIS 397 0.0425
75 ATRIAL FLUTTER 339 0.0424
76 AORTIC ARTERIOSCLEROSIS 109 0.0423
77 VENTRICULAR FIBRILLATION 469 0.0422
78 PURPURA 370 0.0418
79 MELAENA 916 0.0416
80 RASH MACULO-PAPULAR 924 0.0415
81 HAEMORRHAGIC ANAEMIA 182 0.0414
82 DUODENITIS 126 0.0410
83 BLOOD CREATININE INCREASED 2681 0.0410
84 ISCHAEMIC CARDIOMYOPATHY 125 0.0407
85 APLASIA PURE RED CELL 140 0.0407
86 CARDIAC FAILURE ACUTE 271 0.0406
87 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1148 0.0405
88 BLOOD LACTATE DEHYDROGENASE INCREASED 637 0.0402
89 STAPHYLOCOCCAL SEPSIS 198 0.0401
90 TROPONIN INCREASED 305 0.0400
91 CARDIOGENIC SHOCK 572 0.0398
92 TUBULOINTERSTITIAL NEPHRITIS 743 0.0396
93 BLOOD POTASSIUM INCREASED 643 0.0396
94 MIXED LIVER INJURY 119 0.0395
95 RENAL FAILURE 5150 0.0387
96 GLOMERULAR FILTRATION RATE DECREASED 473 0.0385
97 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 157 0.0384
98 EXERCISE TOLERANCE DECREASED 221 0.0384
99 PNEUMONIA FUNGAL 150 0.0380
100 FIBRIN D DIMER INCREASED 134 0.0377
101 TONGUE DISORDER 270 0.0373
102 BLOOD CREATINE INCREASED 164 0.0370
103 ACUTE MYELOID LEUKAEMIA 573 0.0367
104 GASTRITIS EROSIVE 170 0.0364
105 RENAL IMPAIRMENT 3056 0.0363
106 HYPERVOLAEMIA 177 0.0358
107 ATRIOVENTRICULAR BLOCK FIRST DEGREE 155 0.0357
108 MULTIPLE MYELOMA 166 0.0356
109 STAPHYLOCOCCAL BACTERAEMIA 154 0.0354
110 BLOOD BLISTER 110 0.0352
111 APLASTIC ANAEMIA 183 0.0350
112 RIGHT VENTRICULAR FAILURE 243 0.0346
113 RED CELL DISTRIBUTION WIDTH INCREASED 144 0.0346
114 DIVERTICULUM INTESTINAL 151 0.0345
115 RENAL FUNCTION TEST ABNORMAL 160 0.0344
116 CLOSTRIDIUM DIFFICILE COLITIS 364 0.0343
117 DRUG ERUPTION 606 0.0342
118 ELECTROLYTE IMBALANCE 397 0.0341
119 HYPOVOLAEMIC SHOCK 163 0.0340
120 VENTRICULAR HYPOKINESIA 109 0.0339
121 MITRAL VALVE INCOMPETENCE 384 0.0339
122 INTERNATIONAL NORMALISED RATIO INCREASED 965 0.0338
123 PANCYTOPENIA 1891 0.0338
124 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 129 0.0337
125 CYTOMEGALOVIRUS VIRAEMIA 150 0.0337
126 PEMPHIGOID 254 0.0336
127 ENTEROCOCCAL INFECTION 162 0.0335
128 PROTHROMBIN TIME PROLONGED 198 0.0331
129 BREATH SOUNDS ABNORMAL 163 0.0330
130 CARDIAC FAILURE 2650 0.0330
131 ECCHYMOSIS 226 0.0329
132 SQUAMOUS CELL CARCINOMA OF SKIN 199 0.0329
133 TRICUSPID VALVE INCOMPETENCE 261 0.0328
134 ANURIA 282 0.0327
135 HYPONATRAEMIA 1845 0.0327
136 HOSPICE CARE 322 0.0326
137 MYASTHENIA GRAVIS 263 0.0325
138 HYPERLIPIDAEMIA 389 0.0325
139 SERUM FERRITIN INCREASED 171 0.0324
140 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 251 0.0323
141 TRANSFUSION 337 0.0321
142 C-REACTIVE PROTEIN INCREASED 1169 0.0321
143 LEFT VENTRICULAR FAILURE 110 0.0319
144 IRON DEFICIENCY ANAEMIA 294 0.0318
145 ANAEMIA 6074 0.0318
146 ERYTHEMA MULTIFORME 297 0.0318
147 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 188 0.0317
148 AORTIC VALVE INCOMPETENCE 135 0.0317
149 HAEMATOMA 821 0.0317
150 UPPER GASTROINTESTINAL HAEMORRHAGE 532 0.0316
151 COVID-19 PNEUMONIA 372 0.0315
152 CUTANEOUS VASCULITIS 115 0.0315
153 RENAL CYST 250 0.0314
154 ASCITES 925 0.0314
155 CARDIOMEGALY 387 0.0314
156 UROSEPSIS 290 0.0314
157 HYPOMAGNESAEMIA 437 0.0314
158 ATELECTASIS 303 0.0313
159 ATRIAL FIBRILLATION 3041 0.0312
160 HYPOVOLAEMIA 182 0.0311
161 ESCHERICHIA URINARY TRACT INFECTION 132 0.0310
162 OBSTRUCTION 124 0.0310
163 LEFT VENTRICULAR HYPERTROPHY 132 0.0308
164 CORONARY ARTERY STENOSIS 155 0.0308
165 ULCER 489 0.0307
166 LUNG INFILTRATION 271 0.0306
167 HAEMORRHAGIC DIATHESIS 109 0.0306
168 SKIN ULCER 791 0.0306
169 PROSTATOMEGALY 120 0.0305
170 HAEMATOCRIT DECREASED 605 0.0305
171 NEPHROPATHY 284 0.0304
172 INTERNATIONAL NORMALISED RATIO DECREASED 123 0.0303
173 SHOCK HAEMORRHAGIC 247 0.0303
174 BASAL CELL CARCINOMA 472 0.0302
175 PLEURAL EFFUSION 1837 0.0302
176 LOWER GASTROINTESTINAL HAEMORRHAGE 223 0.0301
177 HYPOKALAEMIA 1386 0.0300
178 BLOOD COUNT ABNORMAL 455 0.0300
179 DYSPNOEA EXERTIONAL 1130 0.0300
180 CONGESTIVE CARDIOMYOPATHY 125 0.0300
181 RENAL TUBULAR NECROSIS 294 0.0299
182 BUNDLE BRANCH BLOCK LEFT 127 0.0299
183 HAEMOGLOBIN DECREASED 3070 0.0299
184 METABOLIC ACIDOSIS 950 0.0297
185 ORTHOSTATIC HYPOTENSION 517 0.0297
186 SEPSIS 3307 0.0296
187 HAEMODIALYSIS 248 0.0295
188 BACTERIAL INFECTION 550 0.0295
189 HYPERBILIRUBINAEMIA 305 0.0294
190 CREATININE RENAL CLEARANCE DECREASED 117 0.0292
191 THROMBOCYTOPENIA 3251 0.0290
192 HYPOCALCAEMIA 548 0.0289
193 BRONCHIECTASIS 194 0.0288
194 GENERAL PHYSICAL HEALTH DETERIORATION 3321 0.0287
195 HYPOALBUMINAEMIA 222 0.0285
196 BUNDLE BRANCH BLOCK RIGHT 131 0.0285
197 SUBDURAL HAEMATOMA 408 0.0285
198 FULL BLOOD COUNT ABNORMAL 301 0.0284
199 HAEMATURIA 973 0.0284
200 SEPTIC SHOCK 1229 0.0282
201 PLATELET COUNT DECREASED 2991 0.0280
202 BACTERAEMIA 332 0.0279
203 LACTIC ACIDOSIS 897 0.0277
204 HAEMOGLOBIN ABNORMAL 178 0.0276
205 ELECTROCARDIOGRAM ABNORMAL 217 0.0276
206 RED BLOOD CELL COUNT DECREASED 790 0.0276
207 LEFT VENTRICULAR DYSFUNCTION 185 0.0276
208 ACUTE PULMONARY OEDEMA 155 0.0276
209 ACUTE RESPIRATORY FAILURE 529 0.0275
210 HYPERNATRAEMIA 137 0.0275
211 ERYSIPELAS 138 0.0274
212 VENTRICULAR TACHYCARDIA 453 0.0274
213 HAEMOGLOBIN INCREASED 125 0.0274
214 BLOOD CALCIUM INCREASED 240 0.0273
215 RHABDOMYOLYSIS 1140 0.0273
216 OEDEMA PERIPHERAL 3328 0.0273
217 RENAL INJURY 801 0.0269
218 PETECHIAE 281 0.0269
219 HAEMORRHOIDAL HAEMORRHAGE 131 0.0268
220 LEUKOCYTOSIS 485 0.0268
221 DIALYSIS 379 0.0267
222 WHITE BLOOD CELL COUNT INCREASED 1022 0.0266
223 PULMONARY HYPERTENSION 554 0.0266
224 BRADYCARDIA 1406 0.0265
225 BLOOD MAGNESIUM DECREASED 228 0.0264
226 ASPARTATE AMINOTRANSFERASE INCREASED 1400 0.0263
227 HYDRONEPHROSIS 195 0.0260
228 HYPOXIA 914 0.0259
229 OLIGURIA 161 0.0259
230 PLATELET COUNT ABNORMAL 156 0.0258
231 HYPOGAMMAGLOBULINAEMIA 169 0.0257
232 DERMATITIS BULLOUS 186 0.0257
233 HEPATITIS ACUTE 167 0.0257
234 URINE OUTPUT DECREASED 224 0.0256
235 FEBRILE BONE MARROW APLASIA 108 0.0254
236 GASTROINTESTINAL HAEMORRHAGE 2123 0.0254
237 CHRONIC MYELOID LEUKAEMIA 117 0.0253
238 WHITE BLOOD CELL COUNT ABNORMAL 161 0.0252
239 FLUID OVERLOAD 367 0.0252
240 INCREASED TENDENCY TO BRUISE 232 0.0252
241 ODYNOPHAGIA 150 0.0251
242 DYSLIPIDAEMIA 127 0.0250
243 CYTOPENIA 306 0.0250
244 DISSEMINATED INTRAVASCULAR COAGULATION 350 0.0248
245 KLEBSIELLA INFECTION 125 0.0247
246 TENDONITIS 382 0.0246
247 ALANINE AMINOTRANSFERASE INCREASED 1514 0.0246
248 UMBILICAL HERNIA 115 0.0246
249 CARDIAC FAILURE CONGESTIVE 1969 0.0245
250 DIVERTICULUM 174 0.0245
251 GASTRIC ULCER HAEMORRHAGE 135 0.0243
252 INTERVERTEBRAL DISC DEGENERATION 225 0.0243
253 LIPASE INCREASED 186 0.0243
254 CORONARY ARTERY DISEASE 735 0.0242
255 ACUTE CORONARY SYNDROME 200 0.0241
256 CHOLESTASIS 463 0.0241
257 BLOOD PRESSURE INADEQUATELY CONTROLLED 145 0.0241
258 GAMMA-GLUTAMYLTRANSFERASE INCREASED 534 0.0241
259 ATRIOVENTRICULAR BLOCK COMPLETE 161 0.0240
260 FULL BLOOD COUNT DECREASED 484 0.0240
261 DIFFUSE LARGE B-CELL LYMPHOMA 185 0.0240
262 MULTI-ORGAN FAILURE 415 0.0240
263 AGRANULOCYTOSIS 445 0.0239
264 MYELODYSPLASTIC SYNDROME 345 0.0238
265 INGUINAL HERNIA 145 0.0238
266 OBSTRUCTIVE AIRWAYS DISORDER 265 0.0238
267 ACUTE MYOCARDIAL INFARCTION 701 0.0237
268 SQUAMOUS CELL CARCINOMA 223 0.0237
269 ACIDOSIS 181 0.0237
270 HAEMOPTYSIS 660 0.0236
271 PERICARDIAL EFFUSION 547 0.0236
272 PLATELET COUNT INCREASED 308 0.0236
273 FLUID INTAKE REDUCED 118 0.0236
274 EPISTAXIS 1762 0.0235
275 EJECTION FRACTION DECREASED 366 0.0235
276 SLEEP APNOEA SYNDROME 449 0.0235
277 BLOOD ALKALINE PHOSPHATASE INCREASED 583 0.0235
278 FACE OEDEMA 394 0.0233
279 NEUTROPHIL COUNT DECREASED 950 0.0233
280 VENTRICULAR EXTRASYSTOLES 242 0.0233
281 MYOCARDIAL ISCHAEMIA 265 0.0233
282 DRUG INTERACTION 3694 0.0233
283 BLOOD PRESSURE SYSTOLIC INCREASED 453 0.0232
284 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 174 0.0232
285 DUODENAL ULCER 163 0.0231
286 HYPOTENSION 4633 0.0231
287 RED BLOOD CELL SEDIMENTATION RATE INCREASED 254 0.0229
288 BONE MARROW FAILURE 466 0.0229
289 MYOPATHY 198 0.0229
290 JOINT EFFUSION 158 0.0229
291 DIABETES MELLITUS INADEQUATE CONTROL 405 0.0229
292 ARTERIOSCLEROSIS CORONARY ARTERY 151 0.0228
293 MUCOSAL INFLAMMATION 596 0.0227
294 CELLULITIS 1147 0.0227
295 PRODUCT PRESCRIBING ERROR 541 0.0227
296 DEHYDRATION 2994 0.0224
297 HAEMOLYTIC ANAEMIA 200 0.0223
298 ESCHERICHIA INFECTION 183 0.0222
299 HEPATITIS CHOLESTATIC 134 0.0222
300 PULMONARY OEDEMA 994 0.0222
301 HYPOGLYCAEMIA 1073 0.0221
302 PULMONARY HAEMORRHAGE 173 0.0221
303 PULMONARY CONGESTION 291 0.0221
304 BLOOD BILIRUBIN INCREASED 596 0.0220
305 SPUTUM DISCOLOURED 209 0.0220
306 ANGINA UNSTABLE 142 0.0218
307 ENDOCARDITIS 112 0.0218
308 PSEUDOMONAS INFECTION 187 0.0218
309 LYMPHOPENIA 308 0.0218
310 PANCREATITIS ACUTE 487 0.0216
311 PULMONARY ARTERIAL HYPERTENSION 313 0.0216
312 NOCTURIA 262 0.0216
313 FLANK PAIN 202 0.0215
314 COAGULOPATHY 359 0.0215
315 OEDEMA 1167 0.0215
316 RESPIRATORY FAILURE 1569 0.0215
317 SUBARACHNOID HAEMORRHAGE 219 0.0215
318 HIATUS HERNIA 276 0.0213
319 SPINAL OSTEOARTHRITIS 187 0.0213
320 MOUTH HAEMORRHAGE 156 0.0213
321 HYPERTRANSAMINASAEMIA 147 0.0211
322 URINARY RETENTION 703 0.0210
323 BLOOD ALBUMIN DECREASED 167 0.0210
324 PNEUMONIA BACTERIAL 193 0.0210
325 CONTRAINDICATED PRODUCT ADMINISTERED 636 0.0210
326 CHOLECYSTITIS 250 0.0210
327 ABNORMAL LOSS OF WEIGHT 143 0.0210
328 LARGE INTESTINE POLYP 145 0.0209
329 GENERALISED OEDEMA 259 0.0209
330 PERIPHERAL SENSORY NEUROPATHY 122 0.0209
331 CHOLECYSTITIS ACUTE 118 0.0208
332 LEUKOPENIA 1041 0.0208
333 BLOOD CALCIUM DECREASED 234 0.0208
334 BRONCHOPULMONARY ASPERGILLOSIS 161 0.0207
335 SINUS BRADYCARDIA 200 0.0207
336 LYMPHADENOPATHY 732 0.0207
337 FLUID RETENTION 1050 0.0206
338 FAECALOMA 113 0.0206
339 BLOOD IRON DECREASED 244 0.0205
340 BLOOD SODIUM DECREASED 387 0.0205
341 HICCUPS 168 0.0204
342 SYNOVITIS 369 0.0204
343 PRODUCTIVE COUGH 976 0.0204
344 RENAL DISORDER 952 0.0204
345 LYMPHOCYTE COUNT DECREASED 361 0.0204
346 NEUTROPENIA 2775 0.0204
347 WHITE BLOOD CELL COUNT DECREASED 2209 0.0204
348 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 209 0.0203
349 HEPATOCELLULAR INJURY 288 0.0203
350 ARTERIOSCLEROSIS 191 0.0203
351 CYTOMEGALOVIRUS INFECTION 335 0.0201
352 BLOOD TEST ABNORMAL 283 0.0201
353 BLOOD LACTIC ACID INCREASED 106 0.0201
354 BLOOD CREATINE PHOSPHOKINASE INCREASED 579 0.0201
355 ANGINA PECTORIS 576 0.0201
356 CONCOMITANT DISEASE AGGRAVATED 124 0.0201
357 RECTAL HAEMORRHAGE 863 0.0201
358 ATRIOVENTRICULAR BLOCK 155 0.0200
359 SYNCOPE 2002 0.0200
360 ENTERITIS 128 0.0200
361 ENCEPHALOPATHY 491 0.0200
362 HYPERCHOLESTEROLAEMIA 193 0.0200
363 INTERSTITIAL LUNG DISEASE 967 0.0200
364 HEPATOMEGALY 196 0.0199
365 TACHYPNOEA 271 0.0199
366 ENTEROCOLITIS 115 0.0199
367 DIVERTICULITIS 548 0.0198
368 TRANSAMINASES INCREASED 434 0.0195
369 LIVER FUNCTION TEST ABNORMAL 566 0.0194
370 HEPATIC STEATOSIS 362 0.0194
371 PNEUMONIA 6287 0.0194
372 RESPIRATORY DISTRESS 535 0.0194
373 ENCEPHALITIS 134 0.0194
374 SKIN LACERATION 210 0.0193
375 HAEMATOCHEZIA 1065 0.0193
376 CARDIAC PACEMAKER INSERTION 115 0.0193
377 HEPATITIS 493 0.0192
378 PULMONARY ALVEOLAR HAEMORRHAGE 108 0.0192
379 SOPOR 255 0.0192
380 PYREXIA 6656 0.0192
381 VASCULITIS 224 0.0192
382 CARDIAC MURMUR 166 0.0192
383 GENERALISED ERYTHEMA 109 0.0191
384 DERMATITIS ALLERGIC 241 0.0191
385 CARDIOMYOPATHY 283 0.0191
386 DIZZINESS POSTURAL 185 0.0191
387 CIRCULATORY COLLAPSE 322 0.0189
388 POLYNEUROPATHY 226 0.0189
389 SEASONAL ALLERGY 267 0.0188
390 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 982 0.0188
391 PLASMA CELL MYELOMA 734 0.0188
392 BLOOD PRESSURE DIASTOLIC DECREASED 138 0.0187
393 COLITIS ISCHAEMIC 126 0.0187
394 RASH PRURITIC 1011 0.0186
395 HEPATIC FAILURE 561 0.0186
396 ACUTE RESPIRATORY DISTRESS SYNDROME 329 0.0186
397 ILEUS 231 0.0186
398 JOINT INJURY 397 0.0186
399 OESOPHAGITIS 203 0.0186
400 NEPHROTIC SYNDROME 127 0.0185
401 SUPRAVENTRICULAR TACHYCARDIA 177 0.0185
402 PYELONEPHRITIS 160 0.0184
403 PROTEINURIA 351 0.0184
404 ORAL CANDIDIASIS 243 0.0184
405 LUNG INFECTION 286 0.0184
406 RASH PUSTULAR 134 0.0184
407 CONTUSION 1763 0.0183
408 MYOSITIS 164 0.0183
409 HYPERGLYCAEMIA 666 0.0183
410 HYPERTENSIVE CRISIS 203 0.0182
411 SUDDEN DEATH 193 0.0182
412 CEREBRAL HAEMORRHAGE 649 0.0181
413 GINGIVAL BLEEDING 247 0.0181
414 HEPATIC FUNCTION ABNORMAL 675 0.0181
415 GASTROENTERITIS 263 0.0180
416 ASPIRATION 197 0.0180
417 PNEUMOCYSTIS JIROVECII PNEUMONIA 180 0.0179
418 SHOCK 412 0.0179
419 CHOLANGITIS 111 0.0179
420 NEURALGIA 435 0.0179
421 ARRHYTHMIA 847 0.0179
422 MYOCLONUS 213 0.0178
423 HEPATIC CYTOLYSIS 226 0.0177
424 MICTURITION URGENCY 202 0.0177
425 SINUS TACHYCARDIA 251 0.0177
426 SECOND PRIMARY MALIGNANCY 147 0.0177
427 DECUBITUS ULCER 144 0.0177
428 CONJUNCTIVITIS 326 0.0176
429 PRESYNCOPE 427 0.0175
430 CORONARY ARTERY OCCLUSION 240 0.0175
431 DYSURIA 644 0.0175
432 HYPERTHERMIA 133 0.0174
433 HAEMORRHAGIC STROKE 136 0.0174
434 HAEMATEMESIS 440 0.0173
435 HAEMOLYSIS 134 0.0173
436 STAPHYLOCOCCAL INFECTION 568 0.0172
437 PULMONARY FIBROSIS 330 0.0172
438 PULMONARY TOXICITY 121 0.0171
439 BLOOD POTASSIUM DECREASED 514 0.0171
440 FAECES DISCOLOURED 370 0.0170
441 PNEUMONITIS 464 0.0170
442 MENTAL STATUS CHANGES 471 0.0169
443 LEUKAEMIA 160 0.0169
444 SKIN LESION 465 0.0169
445 OSTEOMYELITIS 306 0.0169
446 GASTRIC ULCER 321 0.0169
447 BLOOD PRESSURE DECREASED 1115 0.0168
448 DELIRIUM 582 0.0168
449 JAUNDICE 451 0.0167
450 HEPATOTOXICITY 372 0.0167
451 RASH GENERALISED 432 0.0167
452 ISCHAEMIC STROKE 296 0.0166
453 CLOSTRIDIUM DIFFICILE INFECTION 362 0.0166
454 PNEUMONIA ASPIRATION 414 0.0166
455 AORTIC ANEURYSM 126 0.0165
456 CONSTIPATION 3610 0.0165
457 NEPHROPATHY TOXIC 185 0.0165
458 EOSINOPHIL COUNT INCREASED 137 0.0164
459 TRANSIENT ISCHAEMIC ATTACK 553 0.0164
460 DRUG-INDUCED LIVER INJURY 514 0.0164
461 GASTRITIS 431 0.0164
462 POST PROCEDURAL HAEMORRHAGE 190 0.0163
463 LIVER FUNCTION TEST INCREASED 350 0.0163
464 POLYURIA 133 0.0162
465 PERIPHERAL SWELLING 2499 0.0162
466 HAEMORRHOIDS 316 0.0162
467 DRUG LEVEL INCREASED 268 0.0162
468 HEART RATE IRREGULAR 365 0.0161
469 TENDERNESS 168 0.0161
470 ASTHENIA 6039 0.0160
471 HYPOPHAGIA 410 0.0160
472 CONFUSIONAL STATE 2581 0.0160
473 SPINAL COMPRESSION FRACTURE 132 0.0159
474 NEUTROPHIL COUNT INCREASED 163 0.0159
475 DEVICE RELATED INFECTION 245 0.0159
476 EXTRASYSTOLES 111 0.0159
477 DISORIENTATION 629 0.0159
478 MUSCLE ATROPHY 201 0.0158
479 INTERNAL HAEMORRHAGE 181 0.0158
480 PROSTATIC SPECIFIC ANTIGEN INCREASED 218 0.0158
481 HAEMORRHAGE INTRACRANIAL 236 0.0158
482 OXYGEN SATURATION DECREASED 887 0.0158
483 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 270 0.0157
484 OBESITY 250 0.0157
485 RIB FRACTURE 322 0.0156
486 NEUROTOXICITY 274 0.0156
487 BLOOD TRIGLYCERIDES INCREASED 276 0.0156
488 ANGIOEDEMA 689 0.0156
489 LIVER DISORDER 690 0.0155
490 LARGE INTESTINE PERFORATION 108 0.0155
491 NEPHROLITHIASIS 713 0.0155
492 DIABETES MELLITUS 1177 0.0154
493 SMALL INTESTINAL OBSTRUCTION 190 0.0154
494 LOWER RESPIRATORY TRACT INFECTION 702 0.0154
495 BLOOD URINE PRESENT 293 0.0154
496 PALLOR 420 0.0154
497 INFUSION RELATED REACTION 1022 0.0154
498 ACUTE HEPATIC FAILURE 209 0.0153
499 MALNUTRITION 171 0.0153
500 FALL 5086 0.0153
501 ALTERED STATE OF CONSCIOUSNESS 331 0.0153
502 ATAXIA 181 0.0152
503 DYSPNOEA 8619 0.0152
504 CARDIAC ARREST 1255 0.0152
505 DECREASED APPETITE 3517 0.0151
506 ORAL PAIN 339 0.0151
507 SKIN CANCER 325 0.0151
508 URINARY INCONTINENCE 447 0.0151
509 ELECTROCARDIOGRAM QT PROLONGED 542 0.0151
510 BODY TEMPERATURE INCREASED 307 0.0150
511 GASTROOESOPHAGEAL REFLUX DISEASE 1211 0.0150
512 STOMATITIS 910 0.0150
513 DIARRHOEA 9677 0.0150
514 BLOOD GLUCOSE FLUCTUATION 164 0.0149
515 CEREBRAL INFARCTION 365 0.0149
516 DECREASED ACTIVITY 161 0.0149
517 LOCALISED INFECTION 360 0.0149
518 WHEEZING 882 0.0149
519 BLOOD DISORDER 119 0.0148
520 DISEASE PROGRESSION 1754 0.0148
521 ANOREXIA 191 0.0148
522 THROMBOSIS 1187 0.0147
523 BURSITIS 179 0.0147
524 HYPOTHYROIDISM 470 0.0147
525 PULMONARY MASS 219 0.0147
526 PHARYNGITIS 180 0.0145
527 LYMPHOMA 224 0.0145
528 HYPERTENSION 3068 0.0145
529 NEUROPATHY PERIPHERAL 1377 0.0145
530 RESPIRATORY TRACT INFECTION 376 0.0144
531 INFLAMMATION 745 0.0144
532 POLLAKIURIA 602 0.0144
533 HEART RATE DECREASED 506 0.0144
534 INTESTINAL PERFORATION 160 0.0142
535 URINARY TRACT INFECTION 2423 0.0142
536 HAEMODYNAMIC INSTABILITY 108 0.0142
537 MUSCULOSKELETAL CHEST PAIN 219 0.0141
538 TORSADE DE POINTES 111 0.0141
539 LUNG DISORDER 693 0.0141
540 CANDIDA INFECTION 238 0.0141
541 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 675 0.0140
542 INFUSION SITE PAIN 181 0.0140
543 CONCUSSION 108 0.0139
544 HEPATIC ENCEPHALOPATHY 130 0.0139
545 COLITIS 528 0.0139
546 SKIN INFECTION 156 0.0139
547 PULMONARY EMBOLISM 1306 0.0137
548 GASTRIC HAEMORRHAGE 158 0.0137
549 DEMENTIA 383 0.0137
550 MYOCARDITIS 157 0.0137
551 DEEP VEIN THROMBOSIS 886 0.0136
552 MUSCULAR WEAKNESS 1549 0.0136
553 LACERATION 128 0.0136
554 SCAB 155 0.0136
555 HEAD INJURY 430 0.0136
556 CHILLS 1586 0.0135
557 ERECTILE DYSFUNCTION 347 0.0135
558 MOUTH ULCERATION 284 0.0135
559 ABDOMINAL PAIN 3133 0.0135
560 TENDON RUPTURE 166 0.0134
561 DEPRESSED LEVEL OF CONSCIOUSNESS 530 0.0134
562 EMPHYSEMA 135 0.0134
563 TOOTH INFECTION 176 0.0133
564 BRONCHITIS 988 0.0133
565 NIGHT SWEATS 429 0.0133
566 OSTEOARTHRITIS 564 0.0133
567 RASH MACULAR 465 0.0133
568 SKIN HAEMORRHAGE 197 0.0133
569 ABDOMINAL DISTENSION 1387 0.0133
570 TASTE DISORDER 269 0.0132
571 RESPIRATORY SYNCYTIAL VIRUS INFECTION 115 0.0132
572 SPINAL PAIN 154 0.0131
573 WOUND 367 0.0131
574 CHOLELITHIASIS 429 0.0131
575 SWOLLEN TONGUE 408 0.0130
576 FUNGAL INFECTION 435 0.0130
577 COUGH 3659 0.0130
578 PANCREATITIS 689 0.0130
579 RASH ERYTHEMATOUS 623 0.0130
580 COLON CANCER 194 0.0130
581 DRUG INTOLERANCE 1253 0.0130
582 TACHYCARDIA 1150 0.0129
583 THIRST 231 0.0129
584 UPPER RESPIRATORY TRACT INFECTION 596 0.0129
585 WOUND INFECTION 141 0.0129
586 INITIAL INSOMNIA 132 0.0129
587 SCIATICA 205 0.0128
588 OCULAR DISCOMFORT 144 0.0128
589 BODY HEIGHT DECREASED 137 0.0128
590 TYPE 2 DIABETES MELLITUS 431 0.0128
591 CHROMATURIA 289 0.0128
592 LETHARGY 734 0.0127
593 INFECTION 1844 0.0127
594 DRY MOUTH 1033 0.0127
595 DIARRHOEA HAEMORRHAGIC 119 0.0127
596 LIVER INJURY 311 0.0127
597 SKIN REACTION 178 0.0126
598 HEPATIC CIRRHOSIS 237 0.0126
599 DYSARTHRIA 474 0.0126
600 MUSCULOSKELETAL PAIN 659 0.0126
601 BLISTER 706 0.0126
602 PARKINSONISM 122 0.0125
603 IMPAIRED HEALING 410 0.0125
604 LABORATORY TEST ABNORMAL 368 0.0125
605 MOTOR DYSFUNCTION 127 0.0124
606 HYPERTHYROIDISM 180 0.0124
607 DYSPHONIA 727 0.0124
608 PNEUMOTHORAX 197 0.0124
609 GROIN PAIN 109 0.0124
610 ECONOMIC PROBLEM 188 0.0124
611 HEMIPARESIS 210 0.0124
612 ARTHRITIS 973 0.0124
613 HALLUCINATION 932 0.0124
614 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 118 0.0123
615 MALIGNANT MELANOMA 165 0.0123
616 RASH PAPULAR 276 0.0123
617 WEIGHT DECREASED 3428 0.0123
618 FLATULENCE 696 0.0123
619 PAIN IN JAW 346 0.0122
620 MOBILITY DECREASED 877 0.0122
621 MEDICATION ERROR 678 0.0122
622 HEPATIC ENZYME INCREASED 828 0.0121
623 CARDIO-RESPIRATORY ARREST 507 0.0121
624 CHEST PAIN 2245 0.0121
625 PERITONITIS 251 0.0121
626 WEIGHT FLUCTUATION 126 0.0120
627 HERPES ZOSTER 690 0.0120
628 BLOOD CHOLESTEROL INCREASED 559 0.0120
629 SWELLING 1122 0.0120
630 PRESCRIBED UNDERDOSE 238 0.0119
631 VITAMIN D DEFICIENCY 116 0.0119
632 COGNITIVE DISORDER 554 0.0119
633 BLOOD PRESSURE FLUCTUATION 284 0.0118
634 AGEUSIA 295 0.0118
635 ABSCESS 188 0.0118
636 BALANCE DISORDER 1014 0.0117
637 LOSS OF CONSCIOUSNESS 1503 0.0117
638 RASH 5103 0.0117
639 BODY TEMPERATURE DECREASED 115 0.0117
640 BLOOD PRESSURE ABNORMAL 232 0.0117
641 PERIPHERAL COLDNESS 160 0.0116
642 PULMONARY THROMBOSIS 127 0.0116
643 HERNIA 225 0.0116
644 FATIGUE 8976 0.0115
645 LIMB INJURY 313 0.0115
646 MIDDLE INSOMNIA 215 0.0115
647 JOINT RANGE OF MOTION DECREASED 154 0.0115
648 CATARACT 683 0.0115
649 JOINT SWELLING 1382 0.0114
650 SKIN DISCOLOURATION 526 0.0114
651 BLOOD PRESSURE INCREASED 1746 0.0114
652 PRURITUS GENERALISED 246 0.0114
653 ROTATOR CUFF SYNDROME 146 0.0114
654 DERMATITIS 238 0.0113
655 CYSTITIS 361 0.0113
656 MYALGIA 1924 0.0113
657 SWELLING FACE 734 0.0113
658 EYELID OEDEMA 131 0.0113
659 BACK PAIN 2608 0.0112
660 DIZZINESS 5547 0.0111
661 HYPOTONIA 111 0.0111
662 CYST 138 0.0111
663 POOR VENOUS ACCESS 115 0.0111
664 THERAPY NON-RESPONDER 499 0.0111
665 SARS-COV-2 TEST POSITIVE 146 0.0110
666 BLOOD GLUCOSE ABNORMAL 204 0.0110
667 ADRENAL INSUFFICIENCY 134 0.0110
668 GLAUCOMA 212 0.0110
669 PSORIATIC ARTHROPATHY 445 0.0110
670 APHASIA 330 0.0109
671 UNRESPONSIVE TO STIMULI 282 0.0109
672 LIGAMENT SPRAIN 108 0.0109
673 HYPERSOMNIA 312 0.0109
674 NODULE 142 0.0109
675 PAIN IN EXTREMITY 3194 0.0108
676 CONDITION AGGRAVATED 3286 0.0108
677 MASS 151 0.0108
678 PRODUCT ADMINISTRATION ERROR 218 0.0108
679 COLD SWEAT 190 0.0108
680 OSTEOPOROSIS 443 0.0108
681 IMMUNODEFICIENCY 160 0.0107
682 MUSCLE SPASMS 1955 0.0106
683 DYSPHAGIA 1008 0.0106
684 KIDNEY INFECTION 208 0.0106
685 CARDIAC DISORDER 991 0.0106
686 FOLLICULITIS 111 0.0106
687 LIP SWELLING 352 0.0106
688 EYE HAEMORRHAGE 141 0.0106
689 MUSCULOSKELETAL STIFFNESS 925 0.0105
690 COVID-19 1852 0.0105
691 CYANOSIS 166 0.0105
692 TOOTH EXTRACTION 131 0.0105
693 ARTHROPATHY 584 0.0105
694 ANHEDONIA 275 0.0105
695 STATUS EPILEPTICUS 118 0.0104
696 NAUSEA 8247 0.0104
697 VOMITING 4879 0.0104
698 OSTEOPENIA 157 0.0103
699 RESPIRATORY DISORDER 308 0.0103
700 PHOTOSENSITIVITY REACTION 170 0.0103
701 SKIN EXFOLIATION 868 0.0103
702 RENAL PAIN 109 0.0103
703 CARPAL TUNNEL SYNDROME 144 0.0103
704 SPINAL FRACTURE 206 0.0103
705 VERTIGO 626 0.0103
706 ERYTHEMA 2099 0.0102
707 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 238 0.0102
708 PRURITUS 3908 0.0102
709 BONE PAIN 595 0.0101
710 HAEMORRHAGE 1061 0.0101
711 BACK DISORDER 165 0.0101
712 CHEST DISCOMFORT 1039 0.0101
713 SKIN DISORDER 337 0.0101
714 DYSPEPSIA 991 0.0101
715 SOMNOLENCE 2027 0.0101
716 ARTHRALGIA 4183 0.0101
717 COMA 477 0.0100
718 HALLUCINATION, VISUAL 211 0.0100
719 SLEEP DISORDER 703 0.0100
720 RETCHING 212 0.0099
721 GAIT DISTURBANCE 1903 0.0099
722 DELUSION 154 0.0099
723 FEELING COLD 275 0.0099
724 BONE DISORDER 180 0.0099
725 MYOCARDIAL INFARCTION 1721 0.0099
726 UPPER LIMB FRACTURE 196 0.0098
727 CARDIOVASCULAR DISORDER 249 0.0098
728 DYSSTASIA 286 0.0098
729 HIP FRACTURE 313 0.0097
730 VIRAL INFECTION 323 0.0097
731 ABDOMINAL PAIN LOWER 245 0.0097
732 DEAFNESS 253 0.0097
733 SINUS DISORDER 191 0.0096
734 LOCAL SWELLING 168 0.0096
735 ORAL HERPES 188 0.0096
736 ABDOMINAL DISCOMFORT 1614 0.0096
737 FLUSHING 978 0.0096
738 INTERVERTEBRAL DISC PROTRUSION 210 0.0096
739 NO THERAPEUTIC RESPONSE 117 0.0096
740 HOT FLUSH 719 0.0095
741 ECZEMA 499 0.0095
742 MUSCULOSKELETAL DISCOMFORT 164 0.0095
743 MUSCULOSKELETAL DISORDER 181 0.0095
744 HYPOACUSIS 407 0.0094
745 MALAISE 4141 0.0094
746 ORAL DISCOMFORT 131 0.0094
747 TREMOR 1564 0.0094
748 IMMUNE SYSTEM DISORDER 124 0.0094
749 EYE INFECTION 106 0.0094
750 POOR QUALITY SLEEP 202 0.0094
751 OROPHARYNGEAL PAIN 866 0.0093
752 POST PROCEDURAL COMPLICATION 179 0.0093
753 INTESTINAL OBSTRUCTION 351 0.0093
754 NEOPLASM 107 0.0093
755 GASTROENTERITIS VIRAL 168 0.0093
756 TREATMENT NONCOMPLIANCE 508 0.0093
757 MUSCLE RIGIDITY 111 0.0093
758 THYROID DISORDER 143 0.0093
759 TOOTH DISORDER 206 0.0093
760 DIPLOPIA 240 0.0092
761 PHOTOPHOBIA 173 0.0092
762 MUSCLE TWITCHING 212 0.0092
763 GLYCOSYLATED HAEMOGLOBIN INCREASED 232 0.0092
764 ABASIA 227 0.0092
765 DRUG TOXICITY 125 0.0092
766 METASTASES TO LUNG 106 0.0092
767 CEREBROVASCULAR ACCIDENT 1551 0.0091
768 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 651 0.0091
769 LIMB DISCOMFORT 283 0.0091
770 NECK PAIN 511 0.0091
771 APHONIA 127 0.0091
772 MALIGNANT NEOPLASM PROGRESSION 924 0.0090
773 NASAL CONGESTION 529 0.0090
774 NEOPLASM PROGRESSION 313 0.0090
775 MACULAR DEGENERATION 107 0.0090
776 WEIGHT INCREASED 2006 0.0089
777 RHINORRHOEA 579 0.0089
778 FEELING HOT 546 0.0089
779 ERUCTATION 172 0.0089
780 DRUG PRESCRIBING ERROR 170 0.0088
781 DYSGEUSIA 657 0.0088
782 PALPITATIONS 1034 0.0088
783 HEART RATE INCREASED 867 0.0087
784 PERICARDITIS 147 0.0087
785 GAIT INABILITY 292 0.0087
786 BLOOD GLUCOSE INCREASED 1646 0.0087
787 DISEASE RECURRENCE 415 0.0087
788 DEATH 7500 0.0087
789 MOVEMENT DISORDER 279 0.0087
790 SINUSITIS 888 0.0087
791 PARALYSIS 124 0.0087
792 METASTASES TO LIVER 152 0.0086
793 RESTLESS LEGS SYNDROME 157 0.0086
794 ABDOMINAL PAIN UPPER 1777 0.0086
795 SECRETION DISCHARGE 108 0.0086
796 OFF LABEL USE 7541 0.0086
797 SENSORY DISTURBANCE 138 0.0086
798 SINUS CONGESTION 116 0.0086
799 HYPERHIDROSIS 1105 0.0086
800 HYPOAESTHESIA 1283 0.0086
801 RESTLESSNESS 313 0.0085
802 FEELING JITTERY 160 0.0084
803 PHARYNGEAL OEDEMA 129 0.0084
804 INFLUENZA 933 0.0084
805 BLINDNESS UNILATERAL 118 0.0084
806 IMPAIRED GASTRIC EMPTYING 114 0.0084
807 METASTASES TO BONE 137 0.0083
808 ASTHMA 943 0.0083
809 EATING DISORDER 177 0.0083
810 FOOT FRACTURE 157 0.0083
811 PARANOIA 142 0.0082
812 OCULAR HYPERAEMIA 390 0.0082
813 JOINT STIFFNESS 215 0.0082
814 FEEDING DISORDER 166 0.0082
815 AMNESIA 532 0.0082
816 LOWER LIMB FRACTURE 157 0.0082
817 INTENTIONAL PRODUCT USE ISSUE 711 0.0081
818 INCREASED APPETITE 155 0.0081
819 EYE PAIN 456 0.0081
820 QUALITY OF LIFE DECREASED 108 0.0080
821 INSOMNIA 2142 0.0080
822 THERAPEUTIC PRODUCT EFFECT DECREASED 359 0.0080
823 RESPIRATORY TRACT CONGESTION 127 0.0080
824 COORDINATION ABNORMAL 111 0.0079
825 MYELOSUPPRESSION 286 0.0079
826 PRESCRIBED OVERDOSE 153 0.0079
827 BLOOD GLUCOSE DECREASED 378 0.0079
828 HYPOKINESIA 114 0.0078
829 PRODUCT DOSE OMISSION 512 0.0078
830 GASTROINTESTINAL DISORDER 701 0.0078
831 NASOPHARYNGITIS 1438 0.0078
832 OSTEONECROSIS OF JAW 193 0.0078
833 KNEE ARTHROPLASTY 164 0.0078
834 TOOTHACHE 141 0.0078
835 HYPERSENSITIVITY 1444 0.0078
836 PARAESTHESIA 1216 0.0077
837 MEMORY IMPAIRMENT 1059 0.0077
838 APATHY 112 0.0077
839 SCAR 131 0.0076
840 THERAPEUTIC RESPONSE DECREASED 463 0.0076
841 GASTRIC DISORDER 260 0.0076
842 PAIN 4642 0.0075
843 SPEECH DISORDER 394 0.0075
844 HEADACHE 4692 0.0075
845 ANKLE FRACTURE 115 0.0074
846 RHEUMATOID ARTHRITIS 843 0.0074
847 UNEVALUABLE EVENT 559 0.0074
848 TINNITUS 338 0.0073
849 EAR PAIN 143 0.0073
850 THROAT IRRITATION 329 0.0073
851 HIP ARTHROPLASTY 112 0.0073
852 LACRIMATION INCREASED 220 0.0073
853 FEMUR FRACTURE 224 0.0072
854 DYSKINESIA 292 0.0072
855 EYE SWELLING 267 0.0072
856 HOSPITALISATION 1099 0.0071
857 DEPRESSION 1624 0.0071
858 ANAPHYLACTIC REACTION 393 0.0071
859 SEDATION 186 0.0071
860 FRACTURE 134 0.0071
861 AGITATION 518 0.0070
862 GALLBLADDER DISORDER 125 0.0070
863 EYE DISORDER 230 0.0070
864 FREQUENT BOWEL MOVEMENTS 188 0.0070
865 VISUAL ACUITY REDUCED 231 0.0069
866 SKIN FISSURES 135 0.0069
867 EAR INFECTION 182 0.0068
868 VISION BLURRED 939 0.0068
869 DEPRESSED MOOD 361 0.0068
870 INTENTIONAL PRODUCT MISUSE 597 0.0068
871 THERAPY INTERRUPTED 486 0.0068
872 PRODUCT USE ISSUE 1271 0.0068
873 PRODUCT USE IN UNAPPROVED INDICATION 1671 0.0067
874 SNEEZING 151 0.0067
875 URTICARIA 1109 0.0066
876 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 112 0.0066
877 ANXIETY 1869 0.0066
878 TOXICITY TO VARIOUS AGENTS 1105 0.0065
879 VISUAL IMPAIRMENT 807 0.0065
880 DISTURBANCE IN ATTENTION 351 0.0065
881 IMPAIRED WORK ABILITY 139 0.0065
882 RESPIRATORY ARREST 179 0.0065
883 DRY EYE 324 0.0065
884 ANAPHYLACTIC SHOCK 164 0.0064
885 FEAR 170 0.0063
886 ROAD TRAFFIC ACCIDENT 264 0.0063
887 FEELING ABNORMAL 1497 0.0062
888 THERAPY CESSATION 319 0.0062
889 NIGHTMARE 215 0.0062
890 TREATMENT FAILURE 514 0.0062
891 DISCOMFORT 378 0.0062
892 EYE PRURITUS 208 0.0062
893 NEOPLASM MALIGNANT 413 0.0062
894 BLINDNESS 252 0.0062
895 PRODUCT DOSE OMISSION IN ERROR 175 0.0062
896 INJURY 434 0.0062
897 FIBROMYALGIA 149 0.0061
898 THINKING ABNORMAL 114 0.0061
899 HEAD DISCOMFORT 108 0.0061
900 MENTAL IMPAIRMENT 147 0.0061
901 PAIN OF SKIN 163 0.0060
902 ILLNESS 623 0.0060
903 ADVERSE DRUG REACTION 542 0.0060
904 INTENTIONAL DOSE OMISSION 172 0.0060
905 EPILEPSY 184 0.0060
906 ACTIVITIES OF DAILY LIVING IMPAIRED 119 0.0060
907 BURNING SENSATION 420 0.0060
908 THROAT TIGHTNESS 161 0.0059
909 PSORIASIS 772 0.0059
910 PRODUCT AVAILABILITY ISSUE 134 0.0059
911 DRY SKIN 780 0.0058
912 ACCIDENTAL OVERDOSE 213 0.0058
913 GLOSSODYNIA 130 0.0058
914 SEIZURE 665 0.0058
915 OSTEONECROSIS 188 0.0057
916 SURGERY 331 0.0056
917 CHOKING 110 0.0056
918 THERAPEUTIC RESPONSE UNEXPECTED 252 0.0056
919 PROCEDURAL PAIN 155 0.0056
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 987 0.0055
921 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 300 0.0055
922 ABNORMAL BEHAVIOUR 216 0.0054
923 DIABETIC KETOACIDOSIS 129 0.0054
924 NERVOUSNESS 280 0.0054
925 ILL-DEFINED DISORDER 323 0.0053
926 NERVOUS SYSTEM DISORDER 165 0.0053
927 INFLUENZA LIKE ILLNESS 435 0.0053
928 CONVULSION 301 0.0053
929 PRODUCT DOSE OMISSION ISSUE 1532 0.0052
930 DRUG DOSE OMISSION 860 0.0052
931 EYE IRRITATION 299 0.0052
932 AGGRESSION 254 0.0051
933 LUNG NEOPLASM MALIGNANT 207 0.0050
934 ALOPECIA 988 0.0050
935 PANCREATIC CARCINOMA 142 0.0049
936 ADVERSE EVENT 451 0.0049
937 EXTRAPYRAMIDAL DISORDER 121 0.0049
938 MIGRAINE 454 0.0048
939 ABNORMAL DREAMS 131 0.0047
940 INCORRECT DOSE ADMINISTERED 1066 0.0047
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 332 0.0047
942 BONE DENSITY DECREASED 145 0.0046
943 MENTAL DISORDER 201 0.0046
944 COLITIS ULCERATIVE 206 0.0046
945 UNDERDOSE 335 0.0046
946 PANIC ATTACK 166 0.0046
947 DRUG ADMINISTRATION ERROR 138 0.0045
948 DRUG INEFFECTIVE 5889 0.0045
949 PSYCHOTIC DISORDER 128 0.0043
950 DRUG RESISTANCE 111 0.0043
951 WRONG TECHNIQUE IN DRUG USAGE PROCESS 156 0.0043
952 PROSTATE CANCER 342 0.0042
953 MOOD ALTERED 112 0.0041
954 DRUG EFFECT INCOMPLETE 147 0.0040
955 OVERDOSE 870 0.0040
956 IRRITABILITY 239 0.0040
957 PREMATURE BABY 118 0.0039
958 EMOTIONAL DISTRESS 469 0.0039
959 COMPLETED SUICIDE 309 0.0037
960 SYSTEMIC LUPUS ERYTHEMATOSUS 128 0.0036
961 GYNAECOMASTIA 110 0.0036
962 THERAPEUTIC RESPONSE SHORTENED 112 0.0034
963 PRODUCT SUBSTITUTION ISSUE 192 0.0033
964 DRUG EFFECT DECREASED 179 0.0033
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 667 0.0033
966 SKIN IRRITATION 150 0.0033
967 SUICIDAL IDEATION 285 0.0031
968 SUICIDE ATTEMPT 182 0.0030
969 PRODUCT QUALITY ISSUE 387 0.0028
970 DEVICE MALFUNCTION 189 0.0027
971 INJECTION SITE BRUISING 213 0.0027
972 DEVICE ISSUE 235 0.0026
973 EXTRA DOSE ADMINISTERED 106 0.0026
974 WITHDRAWAL SYNDROME 108 0.0026
975 DRUG ABUSE 212 0.0025
976 BLADDER CANCER 149 0.0025
977 INJECTION SITE PAIN 761 0.0025
978 ACNE 188 0.0025
979 RENAL CANCER 118 0.0025
980 SKIN BURNING SENSATION 173 0.0024
981 INJECTION SITE HAEMORRHAGE 186 0.0023
982 DERMATITIS ATOPIC 117 0.0022
983 INJECTION SITE PRURITUS 148 0.0022
984 INTENTIONAL OVERDOSE 141 0.0022
985 INJECTION SITE ERYTHEMA 270 0.0022
986 NO ADVERSE EVENT 376 0.0021
987 INJECTION SITE SWELLING 155 0.0020
988 INJECTION SITE REACTION 129 0.0019
989 MATERNAL EXPOSURE DURING PREGNANCY 141 0.0016
990 FOETAL EXPOSURE DURING PREGNANCY 124 0.0015
991 BREAST CANCER 136 0.0015
992 ACCIDENTAL EXPOSURE TO PRODUCT 135 0.0013
993 DRUG WITHDRAWAL SYNDROME 108 0.0012
994 DRUG DEPENDENCE 163 0.0010